GlassScriptPhysician profile
William A Hood
NPI 1326052119
$4,267.60
in general payments reported to CMS, 2019-2025
29 companies · $1,386 in 2025
The $1,386 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $216 · 2021: $691 · 2022: $1,014 · 2023: $344 · 2024: $320 · 2025: $1,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,050 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,049.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $1,740.76 | 2019-2025 | Gelpoint V-Path |
| Abbvie INC. | $599.92 | 2019-2025 | |
| Exeltis, USA INC. | $385.89 | 2021-2025 | Slynd |
| Pfizer INC. | $261.13 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $183.83 | 2020-2023 | Trintellix |
| Therapeuticsmd, INC. | $153.18 | 2019-2022 | |
| Lupin INC. | $102.06 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $98.51 | 2022-2025 | |
| Myriad Women'S Health, INC. | $93.01 | 2023 | Myrisk |
| Organon LLC | $89.93 | 2021-2025 | Nexplanon |
| Intuitive Surgical, INC. | $62.30 | 2019 | |
| Shield Therapeutics INC | $60.21 | 2023-2024 | Accrufer |
| Hologic Sales and Service, LLC | $52.98 | 2019-2024 | Novasure, Myosure Tissue Removal Device |
| Alexion Pharmaceuticals, INC. | $36.13 | 2021-2022 | |
| Scynexis, INC. | $35.52 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $35.47 | 2019-2020 | |
| Baxter Healthcare | $33.07 | 2019-2020 | |
| Davol INC. | $31.74 | 2022 | |
| Conmed Corporation | $29.38 | 2024 | Airseal |
| Sage Therapeutics, LLC | $22.90 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $22.07 | 2024 | Myfembree |
| Abbott Laboratories | $21.26 | 2022 | |
| Astellas Pharma US INC | $20.83 | 2024 | Veozah |
| Coopersurgical, INC. | $20.29 | 2019 | |
| Daiichi Sankyo INC. | $19.93 | 2021 | |
| Smith+Nephew, INC. | $15.12 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.77 | 2022 | |
| Evofem Biosciences, INC. | $13.52 | 2021 | |
| Avion Pharmaceuticals | $11.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.